Original Research
Published on 22 Jul 2022
The Cost-Effectiveness of Tislelizumab Plus Chemotherapy for Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer
in Drugs Outcomes Research and Policies

- 4,584 views
- 15 citations
Original Research
Published on 22 Jul 2022
in Drugs Outcomes Research and Policies
Brief Research Report
Published on 22 Jul 2022
in Drugs Outcomes Research and Policies
Systematic Review
Published on 22 Jul 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 22 Jul 2022
in Drugs Outcomes Research and Policies
Clinical Trial
Published on 22 Jul 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 19 Jul 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 19 Jul 2022
in Drugs Outcomes Research and Policies
Methods
Published on 19 Jul 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 19 Jul 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 18 Jul 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 18 Jul 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 18 Jul 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 18 Jul 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 15 Jul 2022
in Drugs Outcomes Research and Policies
Systematic Review
Published on 14 Jul 2022
in Drugs Outcomes Research and Policies
Clinical Trial
Published on 14 Jul 2022
in Drugs Outcomes Research and Policies